In a double-blind, placebo-controlled trial, supplementation with vitamin C, vitamin E, or beta-carotene did not help in the primary prevention of total cancer incidence or cancer mortality. Medscape Medical News
A biomarker that can complement or surpass PSA in assessing prostate cancer status would be immensely valuable. Can D-dimer levels serve as a useful prognostic indicator? American Journal of Clinical Pathology
This best evidence interview with Catherine Kelly, MD, discusses a highly rated study on the potentially dangerous interaction between SSRIs and tamoxifen in cancer patients. Medscape Hematology-Oncology
A trio of genomic studies point to specific genes and signaling pathways that characterize 2 human cancers. The results suggest a potential for targeted therapies in glioblastoma multiforme and shed light on the mechanisms of tumorigenesis in pancreatic cancer. Medscape Medical News
A urine test may be able to help predict which men with elevated PSA levels yet no positive biopsy result will develop prostate cancer. Medscape Medical News